About: Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Andrea Bacigalupo published February 2019 in Haematologica

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) im Februar 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в лютому 2019 (uk) scholarly article by Andrea Bacigalupo published February 2019 in Haematologica (en)
publication date	wds:Q61803944-EC5C945A-2EAA-490B-9B4C-AE6CF583775B
publication date	2019-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61803944-136F45AB-414D-4C02-9EDF-55D2BFBB76D1
language of work or name	English
cites work	wds:Q61803944-00B61321-AFAE-4645-BE48-4E0FCC67A06E wds:Q61803944-035F8B3D-E0C6-4511-8300-6A0CA5884CF7 wds:Q61803944-0F103A85-A9EC-4DAC-ACFE-7FF2D1807397 wds:Q61803944-36395EDB-EEF4-481B-80FE-F175773348E5 wds:Q61803944-60B67139-96C3-4A4B-B426-F5A960BE7524 wds:Q61803944-6B2F09F1-928D-4A27-87F6-A8331F5DB65F wds:Q61803944-7E601DCA-8ED9-4977-9EDB-F938F9691E60 wds:Q61803944-8DE30AD6-739B-465D-AE99-62B2E8BE66ED wds:Q61803944-A7842027-5091-4506-A58F-2A417AF281FC wds:Q61803944-BF5E9ED1-007B-49C6-89C0-55BAF20FC4AA
cites work	A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplant Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (E Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study Nationwide Survey on the Use of Horse Antithymocyte Globulins (ATGAM) in Patients with Acquired Aplastic Anemia: A Report on Behalf of the French Reference Center for Aplastic Anemia. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. Melphalan-Based Reduced Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved?
author name string	wds:Q61803944-97E0B907-7554-4C3A-BD04-16EE3F11C193
author name string	Andrea Bacigalupo
rdfs:label	Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia (en) Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia (nl)
skos:prefLabel	Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia (en) Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia (nl)
name	Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia (en) Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia (nl)
title	wds:Q61803944-46CE1098-C3F6-4BC2-8C6F-E971E6CCFD4C
title	Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia (en)
page(s)	wds:Q61803944-62A8C1FC-107D-449E-B98D-86C433EA76A9
page(s)	215-216
instance of	wds:Q61803944-021c614a-3bc7-42bd-9969-586d6a2ad6bc wds:Q61803944-251D6490-04BA-4E24-8D6C-BF6F9F61CB58
instance of	editorial scholarly article
main subject	wds:Q61803944-7C494E63-B9D1-4435-885D-E5EFA717837C wds:Q61803944-D4120F2F-CAC4-4700-A3BF-1BA01A8112A1
main subject	aplastic anemia hematology
PubMed ID	wds:Q61803944-61BB2CB7-8748-49B3-8328-35BE788F714C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30705112
PubMed ID	30705112
published in	wds:Q61803944-7C6B8350-3579-469B-A2B3-C7F0C50387F6
published in	Haematologica
issue	wds:Q61803944-76EEABB3-AA33-49DF-BE25-AF9D33E51167
volume	wds:Q61803944-8FBAD916-23B9-4903-BDDE-A884D11A4310
issue	2
volume	104
DOI	wds:Q61803944-786949C9-CFBC-432F-BEB2-B2171FAA6185
DOI	http://dx.doi.org/10.3324/HAEMATOL.2018.207167
DOI	10.3324/HAEMATOL.2018.207167
PMCID	wds:Q61803944-B89BDDCE-0819-4015-86E1-487865113DE8
PMCID	6355485
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61803944
is cites work of	Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globuline, cyclosporine, with or without G-CSF: a Severe Aplastic Anemia Working Party Trial from the European Grou [Progress in diagnosis and treatment in the elderly patients with aplastic anemia]
is cites work of	wds:Q90466702-E2F30AD0-4374-4311-9467-E31B7F6A97A7 wds:Q89550343-D202B12F-72CC-4C45-AB19-72C2E6926558

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software